Skip to main content

Critical Periods of Neuroendocrine Development: Effects of Prenatal Xenobiotics

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 296))

Abstract

It is now generally accepted that the developing fetus may be adversely affected by exposure to drugs and environmental chemicals. The stage of development of the intrauterine host is a major determinant of the resultant drug or chemical action. With rare exception, all foreign compounds are transmitted across the placenta, and depending upon their solubility and chemical structure, achieve varying concentrations in the fetus. Historically, the concept that external agents could adversely effect the fetus was first expounded by Gregg1 in Australia nearly 50 years ago when he demonstrated that rubella infection in the mother could lead to congenital cataracts in the newborn infant. During the several decades following Gregg’s report, most concern regarding drug effects on the fetus had to do with the perinatal period, particularly with the effect of narcotics and analgesics on the ability of the newborn infant to sustain respiration following delivery.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. N. M. Gregg, Congenital cataract following German measles in the mother, Trans Ophthalmol Soc Aust. 3:35–41 (1941).

    Google Scholar 

  2. C. Gupta and H. Karavolas, Lowered ovarian conversion of 14C-pregnenolone and other metabolites during phenobarbital block of PMS-induced ovulation in immature rats: Inhibition of 3a-hydroxysteroid denydrogenation, Endocrinol 92:117–124 (1973).

    Article  CAS  Google Scholar 

  3. D. Trolle, Decrease of total serum bilirubin concentration in newborn infants after phenobarbital treatment. Lancet 2:705–710 (1968).

    Article  PubMed  CAS  Google Scholar 

  4. C. Gupta and S. J. Yaffe, Reproductive dysfunction in female offspring after prenatal exposure to phenobarbital: Critical period of action. Pediatr Res 15:1488–1491 (1981).

    Article  PubMed  CAS  Google Scholar 

  5. C. Gupta, B. R. Sonawane, S. J. Yaffe, B. H., Phenobarbital exposure in utero: Alterations in female reproductive functions in rats, Science 208:508–510 (1980).

    Article  PubMed  CAS  Google Scholar 

  6. B. R. Sonawane and S. J. Yaffe, Delayed effects of drug exposure during pregnancy: Reproductive function. Biol Res in Pregnancy 4(2):48–55 (1983).

    CAS  Google Scholar 

  7. C. Gupta, S. J. Yaffe, and B. H. Shapiro, Prenatal exposure to phenobarbital permanently decreases testosterone and causes reproductive dysfunction. Science 216:640–642 (1982).

    Article  PubMed  CAS  Google Scholar 

  8. C. Gupta, B. H. Shapiro, and S. J. Yaffe. Reproductive function in male rats following prenatal, exposure to phenobarbital. Ped Pharmacol 1:55–62 (1980).

    CAS  Google Scholar 

  9. T. Valaes, S. Petmezaki, and S. A. Doxiadis SA, Effect on neonatal hyperbilirubinemia of phenobarbital during pregnancy or after birth: practical value of the treatment in a population with high risk of unexplained severe neonatal jaundice, in: “Bilirubin Metabolism in the Newborn.” Birth Defects Original Article Series, The National Foundation, March of Dimes 6:46 (1970).

    Google Scholar 

  10. T. Valaes, K. Kipouros, S. Petmezaki, S. M. Solman, S. A. Doxiadis. Effectiveness and safety of prenatal phrnobarbital for the prevention of neonatal jaundice. Pediatr Res 14:947 (1980).

    Article  PubMed  CAS  Google Scholar 

  11. The second follow-up of the Lesbos cohort was designed and organized by T. Valaes, S. J. Yaffe, G. Chrousos and E. Susman. It was carried out under NIH Contract No. NICHD-CRMC-84–35.

    Google Scholar 

  12. W. A. Marshall and J. M. Tanner, Variation in the pattern of pubertal change in boys. Arch Pis Child 45:13–23 (1970).

    Article  CAS  Google Scholar 

  13. W. A. Marshall, J. M. Tanner, Variation in the pattern of pubertal change in girls. Arch Pis Child 44:291–301 (1969).

    Article  CAS  Google Scholar 

  14. D. Wechsler, Wechsler Intelligence Scale for Children Revised. San Antonio, TX: The Psychological Corporation, 1974.

    Google Scholar 

  15. T. M. Achenbach, C. S. Edelbrock, Manual for the Child Behavior Checklist and the Revised Child Behavior Profile. Burlington, VT: University of Vermont, Department of Psychiatry, 1983.

    Google Scholar 

  16. D. Offer, E. Ostrov, and K. I. Howard, The Offer Self-Image Questionnaire for Adolescents: A Manual. Chicago: Michael Reese Hospital, 1977.

    Google Scholar 

  17. T. M. Achenbach and C. S. Edelbrock, Manual for the Youth Self-Report and Profile. Burlington, VT: University of Vermont, Department of Psychiatry, 1987.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Yaffe, S.J., Dorn, L.D. (1991). Critical Periods of Neuroendocrine Development: Effects of Prenatal Xenobiotics. In: Timiras, P.S., Privat, A., Giacobini, E., Lauder, J., Vernadakis, A. (eds) Plasticity and Regeneration of the Nervous System. Advances in Experimental Medicine and Biology, vol 296. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8047-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8047-4_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8049-8

  • Online ISBN: 978-1-4684-8047-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics